Selected research
Market Structure
Global Digital Chronic Disease Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Digital Chronic Disease Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Digital Chronic Disease Management include S3 Connected Health, WellDoc, AstraZeneca, NTT DATA, Credo Health Services, Dawn Health, Bayer, Medtronic and Teladoc Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Digital Chronic Disease Management market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Digital Chronic Disease Management and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Digital Chronic Disease Management revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Digital Chronic Disease Management market size, projected growth trends, production technologies, key applications, and end-use industries.
Digital Chronic Disease Management Segment by Company
S3 Connected Health
WellDoc
AstraZeneca
NTT DATA
Credo Health Services
Dawn Health
Bayer
Medtronic
Teladoc Health
ScienceSoft
TriZetto Healthcare (Cognizant)
Omada Health
Phable
Pack Health
Epic Systems
Pathmate
EveryDose
Aptar Digital Health
VITech
ClouDr Group
JD Health
Ali Health
Ping An Good Doctor
We Doctor Group
Wei Mai
Medlinker
Digital Chronic Disease Management Segment by Type
Charge
Free
Digital Chronic Disease Management Segment by Application
Medical Institutions
Pharmacy
Chronic Disease Patients
Digital Chronic Disease Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Chronic Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Chronic Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Chronic Disease Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Digital Chronic Disease Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Chronic Disease Management industry.
Chapter 3: Detailed analysis of Digital Chronic Disease Management companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Chronic Disease Managementrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Digital Chronic Disease Management Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of Charge
Table 3. Key Players of Free
Table 4. Global Digital Chronic Disease Management Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 5. Key Players of Medical Institutions
Table 6. Key Players of Pharmacy
Table 7. Key Players of Chronic Disease Patients
Table 8. Global Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 9. Global Digital Chronic Disease Management Market Size by Region (2021-2026) & (US$ Million)
Table 10. Global Digital Chronic Disease Management Market Share by Region (2021-2026)
Table 11. Global Digital Chronic Disease Management Market Size by Region (2027-2032) & (US$ Million)
Table 12. Global Digital Chronic Disease Management Market Share by Region (2027-2032)
Table 13. Digital Chronic Disease Management Industry Trends
Table 14. Digital Chronic Disease Management Industry Drivers
Table 15. Digital Chronic Disease Management Industry Opportunities and Challenges
Table 16. Digital Chronic Disease Management Industry Restraints
Table 17. Global Digital Chronic Disease Management Revenue by Company (US$ Million) & (2021-2026)
Table 18. Global Digital Chronic Disease Management Revenue Market Share by Company (2021-2026)
Table 19. Global Digital Chronic Disease Management Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 20. Global Digital Chronic Disease Management Key Company Head Office and Area Served
Table 21. Global Digital Chronic Disease Management Company, Product Type & Application
Table 22. Global Digital Chronic Disease Management Company Establishment Date
Table 23. Global Company Market Concentration Ratio (CR5 and HHI)
Table 24. Global Digital Chronic Disease Management by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 25. Global Digital Chronic Disease Management Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 27. Global Digital Chronic Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 28. Global Digital Chronic Disease Management Revenue Market Share by Type (2021-2026)
Table 29. Global Digital Chronic Disease Management Revenue Market Share by Type (2027-2032)
Table 30. Global Digital Chronic Disease Management Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 32. Global Digital Chronic Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 33. Global Digital Chronic Disease Management Revenue Market Share by Application (2021-2026)
Table 34. Global Digital Chronic Disease Management Revenue Market Share by Application (2027-2032)
Table 35. S3 Connected Health Company Information
Table 36. S3 Connected Health Business Overview
Table 37. S3 Connected Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 38. S3 Connected Health Digital Chronic Disease Management Product Portfolio
Table 39. S3 Connected Health Recent Development
Table 40. WellDoc Company Information
Table 41. WellDoc Business Overview
Table 42. WellDoc Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 43. WellDoc Digital Chronic Disease Management Product Portfolio
Table 44. WellDoc Recent Development
Table 45. AstraZeneca Company Information
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 48. AstraZeneca Digital Chronic Disease Management Product Portfolio
Table 49. AstraZeneca Recent Development
Table 50. NTT DATA Company Information
Table 51. NTT DATA Business Overview
Table 52. NTT DATA Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 53. NTT DATA Digital Chronic Disease Management Product Portfolio
Table 54. NTT DATA Recent Development
Table 55. Credo Health Services Company Information
Table 56. Credo Health Services Business Overview
Table 57. Credo Health Services Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 58. Credo Health Services Digital Chronic Disease Management Product Portfolio
Table 59. Credo Health Services Recent Development
Table 60. Dawn Health Company Information
Table 61. Dawn Health Business Overview
Table 62. Dawn Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 63. Dawn Health Digital Chronic Disease Management Product Portfolio
Table 64. Dawn Health Recent Development
Table 65. Bayer Company Information
Table 66. Bayer Business Overview
Table 67. Bayer Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 68. Bayer Digital Chronic Disease Management Product Portfolio
Table 69. Bayer Recent Development
Table 70. Medtronic Company Information
Table 71. Medtronic Business Overview
Table 72. Medtronic Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 73. Medtronic Digital Chronic Disease Management Product Portfolio
Table 74. Medtronic Recent Development
Table 75. Teladoc Health Company Information
Table 76. Teladoc Health Business Overview
Table 77. Teladoc Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 78. Teladoc Health Digital Chronic Disease Management Product Portfolio
Table 79. Teladoc Health Recent Development
Table 80. ScienceSoft Company Information
Table 81. ScienceSoft Business Overview
Table 82. ScienceSoft Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 83. ScienceSoft Digital Chronic Disease Management Product Portfolio
Table 84. ScienceSoft Recent Development
Table 85. TriZetto Healthcare (Cognizant) Company Information
Table 86. TriZetto Healthcare (Cognizant) Business Overview
Table 87. TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 88. TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio
Table 89. TriZetto Healthcare (Cognizant) Recent Development
Table 90. Omada Health Company Information
Table 91. Omada Health Business Overview
Table 92. Omada Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 93. Omada Health Digital Chronic Disease Management Product Portfolio
Table 94. Omada Health Recent Development
Table 95. Phable Company Information
Table 96. Phable Business Overview
Table 97. Phable Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 98. Phable Digital Chronic Disease Management Product Portfolio
Table 99. Phable Recent Development
Table 100. Pack Health Company Information
Table 101. Pack Health Business Overview
Table 102. Pack Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 103. Pack Health Digital Chronic Disease Management Product Portfolio
Table 104. Pack Health Recent Development
Table 105. Epic Systems Company Information
Table 106. Epic Systems Business Overview
Table 107. Epic Systems Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 108. Epic Systems Digital Chronic Disease Management Product Portfolio
Table 109. Epic Systems Recent Development
Table 110. Pathmate Company Information
Table 111. Pathmate Business Overview
Table 112. Pathmate Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 113. Pathmate Digital Chronic Disease Management Product Portfolio
Table 114. Pathmate Recent Development
Table 115. EveryDose Company Information
Table 116. EveryDose Business Overview
Table 117. EveryDose Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 118. EveryDose Digital Chronic Disease Management Product Portfolio
Table 119. EveryDose Recent Development
Table 120. Aptar Digital Health Company Information
Table 121. Aptar Digital Health Business Overview
Table 122. Aptar Digital Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 123. Aptar Digital Health Digital Chronic Disease Management Product Portfolio
Table 124. Aptar Digital Health Recent Development
Table 125. VITech Company Information
Table 126. VITech Business Overview
Table 127. VITech Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 128. VITech Digital Chronic Disease Management Product Portfolio
Table 129. VITech Recent Development
Table 130. ClouDr Group Company Information
Table 131. ClouDr Group Business Overview
Table 132. ClouDr Group Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 133. ClouDr Group Digital Chronic Disease Management Product Portfolio
Table 134. ClouDr Group Recent Development
Table 135. JD Health Company Information
Table 136. JD Health Business Overview
Table 137. JD Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 138. JD Health Digital Chronic Disease Management Product Portfolio
Table 139. JD Health Recent Development
Table 140. Ali Health Company Information
Table 141. Ali Health Business Overview
Table 142. Ali Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 143. Ali Health Digital Chronic Disease Management Product Portfolio
Table 144. Ali Health Recent Development
Table 145. Ping An Good Doctor Company Information
Table 146. Ping An Good Doctor Business Overview
Table 147. Ping An Good Doctor Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 148. Ping An Good Doctor Digital Chronic Disease Management Product Portfolio
Table 149. Ping An Good Doctor Recent Development
Table 150. We Doctor Group Company Information
Table 151. We Doctor Group Business Overview
Table 152. We Doctor Group Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 153. We Doctor Group Digital Chronic Disease Management Product Portfolio
Table 154. We Doctor Group Recent Development
Table 155. Wei Mai Company Information
Table 156. Wei Mai Business Overview
Table 157. Wei Mai Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 158. Wei Mai Digital Chronic Disease Management Product Portfolio
Table 159. Wei Mai Recent Development
Table 160. Medlinker Company Information
Table 161. Medlinker Business Overview
Table 162. Medlinker Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 163. Medlinker Digital Chronic Disease Management Product Portfolio
Table 164. Medlinker Recent Development
Table 165. North America Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 166. North America Digital Chronic Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 167. North America Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 168. North America Digital Chronic Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 169. North America Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 170. North America Digital Chronic Disease Management Market Size by Country (2021-2026)
Table 171. North America Digital Chronic Disease Management Market Size by Country (2027-2032)
Table 172. Europe Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 173. Europe Digital Chronic Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 174. Europe Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 175. Europe Digital Chronic Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 176. Europe Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 177. Europe Digital Chronic Disease Management Market Size by Country (2021-2026)
Table 178. Europe Digital Chronic Disease Management Market Size by Country (2027-2032)
Table 179. China Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 180. China Digital Chronic Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 181. China Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 182. China Digital Chronic Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 183. Asia Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 184. Asia Digital Chronic Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 185. Asia Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 186. Asia Digital Chronic Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 187. Asia Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 188. Asia Digital Chronic Disease Management Market Size by Country (2021-2026)
Table 189. Asia Digital Chronic Disease Management Market Size by Country (2027-2032)
Table 190. South America, Middle East & Africa Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 191. South America, Middle East & Africa Digital Chronic Disease Management Market Size by Type (2027-2032) & (US$ Million)
Table 192. South America, Middle East & Africa Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 193. South America, Middle East & Africa Digital Chronic Disease Management Market Size by Application (2027-2032) & (US$ Million)
Table 194. South America, Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 195. South America, Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021-2026)
Table 196. South America, Middle East & Africa Digital Chronic Disease Management Market Size by Country (2027-2032)
Table 197. Research Programs/Design for This Report
Table 198. Authors List of This Report
Table 199. Secondary Sources
Table 200. Primary Sources
List of Figures
Figure 1. Digital Chronic Disease Management Product Image
Figure 2. Global Digital Chronic Disease Management Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Digital Chronic Disease Management Market Share by Type: 2025 VS 2032
Figure 4. Charge Image
Figure 5. Free Image
Figure 6. Global Digital Chronic Disease Management Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 7. Global Digital Chronic Disease Management Market Share by Application: 2025 VS 2032
Figure 8. Medical Institutions Image
Figure 9. Pharmacy Image
Figure 10. Chronic Disease Patients Image
Figure 11. Global Digital Chronic Disease Management Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 13. Global Digital Chronic Disease Management Market Share by Region: 2025 VS 2032
Figure 14. Years Considered
Figure 15. Global Digital Chronic Disease Management Market Share by Players in 2025
Figure 16. Global Top 5 and 10 Digital Chronic Disease Management Players Market Share by Revenue in 2025
Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Digital Chronic Disease Management Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Digital Chronic Disease Management Revenue Market Share by Type (2021-2032)
Figure 20. Global Digital Chronic Disease Management Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 21. Global Digital Chronic Disease Management Revenue Market Share by Application (2021-2032)
Figure 22. North America Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 23. North America Digital Chronic Disease Management Market Share by Type (2021-2032)
Figure 24. North America Digital Chronic Disease Management Market Share by Application (2021-2032)
Figure 25. North America Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 26. United States Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 27. Canada Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 28. Mexico Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 29. Europe Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 30. Europe Digital Chronic Disease Management Market Share by Type (2021-2032)
Figure 31. Europe Digital Chronic Disease Management Market Share by Application (2021-2032)
Figure 32. Europe Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 33. Germany Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 34. France Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 35. U.K. Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 36. Italy Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 37. Russia Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 39. China Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 40. China Digital Chronic Disease Management Market Share by Type (2021-2032)
Figure 41. China Digital Chronic Disease Management Market Share by Application (2021-2032)
Figure 42. Asia Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 43. Asia Digital Chronic Disease Management Market Share by Type (2021-2032)
Figure 44. Asia Digital Chronic Disease Management Market Share by Application (2021-2032)
Figure 45. Asia Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 46. Japan Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 47. South Korea Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 48. Taiwan Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 50. India Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 51. Australia Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 52. South America, Middle East & Africa Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 53. South America, Middle East & Africa Digital Chronic Disease Management Market Share by Type (2021-2032)
Figure 54. South America, Middle East & Africa Digital Chronic Disease Management Market Share by Application (2021-2032)
Figure 55. South America, Middle East & Africa Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 56. Brazil Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 57. South Africa Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 58. Saudi Arabia Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 59. Turkey Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 60. Argentina Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 61. UAE Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 62. Egypt Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 63. Chile Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million)
Figure 64. Research Process
Figure 65. Key Executives Interviewed
Scope & coverage.
Types
- Charge
- Free
Applications
- Medical Institutions
- Pharmacy
- Chronic Disease Patients
Companies covered
- S3 Connected Health
- WellDoc
- AstraZeneca
- NTT DATA
- Credo Health Services
- Dawn Health
- Bayer
- Medtronic
- Teladoc Health
- ScienceSoft
- TriZetto Healthcare (Cognizant)
- Omada Health
- Phable
- Pack Health
- Epic Systems
- Pathmate
- EveryDose
- Aptar Digital Health
- VITech
- ClouDr Group
- JD Health
- Ali Health
- Ping An Good Doctor
- We Doctor Group
- Wei Mai
- Medlinker
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Digital Chronic Disease Management Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Charge
- 1.2.3 Free
- 1.3 Market Analysis by Application
- 1.3.1 Global Digital Chronic Disease Management Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Medical Institutions
- 1.3.3 Pharmacy
- 1.3.4 Chronic Disease Patients
- 1.4 Global Market Growth Prospects
- 1.5 Global Digital Chronic Disease Management Growth Trends by Region
- 1.5.1 Global Digital Chronic Disease Management Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Digital Chronic Disease Management Market Size by Region (2021-2026)
- 1.5.3 Digital Chronic Disease Management Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Digital Chronic Disease Management Market Dynamics
- 2.1 Digital Chronic Disease Management Industry Trends
- 2.2 Digital Chronic Disease Management Industry Drivers
- 2.3 Digital Chronic Disease Management Industry Opportunities and Challenges
- 2.4 Digital Chronic Disease Management Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Digital Chronic Disease Management Revenue by Company (2021-2026)
- 3.2 Global Digital Chronic Disease Management Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Digital Chronic Disease Management Key Company Head office and Area Served
- 3.4 Global Digital Chronic Disease Management Company, Product Type & Application
- 3.5 Global Digital Chronic Disease Management Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Digital Chronic Disease Management Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Digital Chronic Disease Management Players Market Share by Revenue in 2025
- 3.6.3 2025 Digital Chronic Disease Management Tier 1, Tier 2, and Tier 3
4 Digital Chronic Disease Management Market by Type
- 4.1 Global Digital Chronic Disease Management Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Digital Chronic Disease Management Market Size by Type (2021-2032)
- 4.3 Global Digital Chronic Disease Management Market Size Share by Type (2021-2032)
5 Digital Chronic Disease Management Market by Application
- 5.1 Global Digital Chronic Disease Management Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Digital Chronic Disease Management Market Size by Application (2021-2032)
- 5.3 Global Digital Chronic Disease Management Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 S3 Connected Health
- 6.1.1 S3 Connected Health Company Information
- 6.1.2 S3 Connected Health Business Overview
- 6.1.3 S3 Connected Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 S3 Connected Health Digital Chronic Disease Management Product Portfolio
- 6.1.5 S3 Connected Health Recent Developments
- 6.2 WellDoc
- 6.2.1 WellDoc Company Information
- 6.2.2 WellDoc Business Overview
- 6.2.3 WellDoc Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 WellDoc Digital Chronic Disease Management Product Portfolio
- 6.2.5 WellDoc Recent Developments
- 6.3 AstraZeneca
- 6.3.1 AstraZeneca Company Information
- 6.3.2 AstraZeneca Business Overview
- 6.3.3 AstraZeneca Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 AstraZeneca Digital Chronic Disease Management Product Portfolio
- 6.3.5 AstraZeneca Recent Developments
- 6.4 NTT DATA
- 6.4.1 NTT DATA Company Information
- 6.4.2 NTT DATA Business Overview
- 6.4.3 NTT DATA Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 NTT DATA Digital Chronic Disease Management Product Portfolio
- 6.4.5 NTT DATA Recent Developments
- 6.5 Credo Health Services
- 6.5.1 Credo Health Services Company Information
- 6.5.2 Credo Health Services Business Overview
- 6.5.3 Credo Health Services Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Credo Health Services Digital Chronic Disease Management Product Portfolio
- 6.5.5 Credo Health Services Recent Developments
- 6.6 Dawn Health
- 6.6.1 Dawn Health Company Information
- 6.6.2 Dawn Health Business Overview
- 6.6.3 Dawn Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Dawn Health Digital Chronic Disease Management Product Portfolio
- 6.6.5 Dawn Health Recent Developments
- 6.7 Bayer
- 6.7.1 Bayer Company Information
- 6.7.2 Bayer Business Overview
- 6.7.3 Bayer Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Bayer Digital Chronic Disease Management Product Portfolio
- 6.7.5 Bayer Recent Developments
- 6.8 Medtronic
- 6.8.1 Medtronic Company Information
- 6.8.2 Medtronic Business Overview
- 6.8.3 Medtronic Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Medtronic Digital Chronic Disease Management Product Portfolio
- 6.8.5 Medtronic Recent Developments
- 6.9 Teladoc Health
- 6.9.1 Teladoc Health Company Information
- 6.9.2 Teladoc Health Business Overview
- 6.9.3 Teladoc Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Teladoc Health Digital Chronic Disease Management Product Portfolio
- 6.9.5 Teladoc Health Recent Developments
- 6.10 ScienceSoft
- 6.10.1 ScienceSoft Company Information
- 6.10.2 ScienceSoft Business Overview
- 6.10.3 ScienceSoft Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 ScienceSoft Digital Chronic Disease Management Product Portfolio
- 6.10.5 ScienceSoft Recent Developments
- 6.11 TriZetto Healthcare (Cognizant)
- 6.11.1 TriZetto Healthcare (Cognizant) Company Information
- 6.11.2 TriZetto Healthcare (Cognizant) Business Overview
- 6.11.3 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio
- 6.11.5 TriZetto Healthcare (Cognizant) Recent Developments
- 6.12 Omada Health
- 6.12.1 Omada Health Company Information
- 6.12.2 Omada Health Business Overview
- 6.12.3 Omada Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Omada Health Digital Chronic Disease Management Product Portfolio
- 6.12.5 Omada Health Recent Developments
- 6.13 Phable
- 6.13.1 Phable Company Information
- 6.13.2 Phable Business Overview
- 6.13.3 Phable Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Phable Digital Chronic Disease Management Product Portfolio
- 6.13.5 Phable Recent Developments
- 6.14 Pack Health
- 6.14.1 Pack Health Company Information
- 6.14.2 Pack Health Business Overview
- 6.14.3 Pack Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Pack Health Digital Chronic Disease Management Product Portfolio
- 6.14.5 Pack Health Recent Developments
- 6.15 Epic Systems
- 6.15.1 Epic Systems Company Information
- 6.15.2 Epic Systems Business Overview
- 6.15.3 Epic Systems Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Epic Systems Digital Chronic Disease Management Product Portfolio
- 6.15.5 Epic Systems Recent Developments
- 6.16 Pathmate
- 6.16.1 Pathmate Company Information
- 6.16.2 Pathmate Business Overview
- 6.16.3 Pathmate Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Pathmate Digital Chronic Disease Management Product Portfolio
- 6.16.5 Pathmate Recent Developments
- 6.17 EveryDose
- 6.17.1 EveryDose Company Information
- 6.17.2 EveryDose Business Overview
- 6.17.3 EveryDose Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 EveryDose Digital Chronic Disease Management Product Portfolio
- 6.17.5 EveryDose Recent Developments
- 6.18 Aptar Digital Health
- 6.18.1 Aptar Digital Health Company Information
- 6.18.2 Aptar Digital Health Business Overview
- 6.18.3 Aptar Digital Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Aptar Digital Health Digital Chronic Disease Management Product Portfolio
- 6.18.5 Aptar Digital Health Recent Developments
- 6.19 VITech
- 6.19.1 VITech Company Information
- 6.19.2 VITech Business Overview
- 6.19.3 VITech Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 VITech Digital Chronic Disease Management Product Portfolio
- 6.19.5 VITech Recent Developments
- 6.20 ClouDr Group
- 6.20.1 ClouDr Group Company Information
- 6.20.2 ClouDr Group Business Overview
- 6.20.3 ClouDr Group Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 ClouDr Group Digital Chronic Disease Management Product Portfolio
- 6.20.5 ClouDr Group Recent Developments
- 6.21 JD Health
- 6.21.1 JD Health Company Information
- 6.21.2 JD Health Business Overview
- 6.21.3 JD Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 JD Health Digital Chronic Disease Management Product Portfolio
- 6.21.5 JD Health Recent Developments
- 6.22 Ali Health
- 6.22.1 Ali Health Company Information
- 6.22.2 Ali Health Business Overview
- 6.22.3 Ali Health Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 Ali Health Digital Chronic Disease Management Product Portfolio
- 6.22.5 Ali Health Recent Developments
- 6.23 Ping An Good Doctor
- 6.23.1 Ping An Good Doctor Company Information
- 6.23.2 Ping An Good Doctor Business Overview
- 6.23.3 Ping An Good Doctor Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.23.4 Ping An Good Doctor Digital Chronic Disease Management Product Portfolio
- 6.23.5 Ping An Good Doctor Recent Developments
- 6.24 We Doctor Group
- 6.24.1 We Doctor Group Company Information
- 6.24.2 We Doctor Group Business Overview
- 6.24.3 We Doctor Group Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.24.4 We Doctor Group Digital Chronic Disease Management Product Portfolio
- 6.24.5 We Doctor Group Recent Developments
- 6.25 Wei Mai
- 6.25.1 Wei Mai Company Information
- 6.25.2 Wei Mai Business Overview
- 6.25.3 Wei Mai Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.25.4 Wei Mai Digital Chronic Disease Management Product Portfolio
- 6.25.5 Wei Mai Recent Developments
- 6.26 Medlinker
- 6.26.1 Medlinker Company Information
- 6.26.2 Medlinker Business Overview
- 6.26.3 Medlinker Digital Chronic Disease Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.26.4 Medlinker Digital Chronic Disease Management Product Portfolio
- 6.26.5 Medlinker Recent Developments
7 North America
- 7.1 North America Digital Chronic Disease Management Market Size (2021-2032)
- 7.2 North America Digital Chronic Disease Management Market Size by Type
- 7.2.1 North America Digital Chronic Disease Management Market Size by Type (2021-2026)
- 7.2.2 North America Digital Chronic Disease Management Market Size by Type (2027-2032)
- 7.2.3 North America Digital Chronic Disease Management Market Share by Type (2021-2032)
- 7.3 North America Digital Chronic Disease Management Market Size by Application
- 7.3.1 North America Digital Chronic Disease Management Market Size by Application (2021-2026)
- 7.3.2 North America Digital Chronic Disease Management Market Size by Application (2027-2032)
- 7.3.3 North America Digital Chronic Disease Management Market Share by Application (2021-2032)
- 7.4 North America Digital Chronic Disease Management Market Size by Country
- 7.4.1 North America Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Digital Chronic Disease Management Market Size by Country (2021-2026)
- 7.4.3 North America Digital Chronic Disease Management Market Size by Country (2027-2032)
- 7.4.4 North America Digital Chronic Disease Management Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Digital Chronic Disease Management Market Size (2021-2032)
- 8.2 Europe Digital Chronic Disease Management Market Size by Type
- 8.2.1 Europe Digital Chronic Disease Management Market Size by Type (2021-2026)
- 8.2.2 Europe Digital Chronic Disease Management Market Size by Type (2027-2032)
- 8.2.3 Europe Digital Chronic Disease Management Market Share by Type (2021-2032)
- 8.3 Europe Digital Chronic Disease Management Market Size by Application
- 8.3.1 Europe Digital Chronic Disease Management Market Size by Application (2021-2026)
- 8.3.2 Europe Digital Chronic Disease Management Market Size by Application (2027-2032)
- 8.3.3 Europe Digital Chronic Disease Management Market Share by Application (2021-2032)
- 8.4 Europe Digital Chronic Disease Management Market Size by Country
- 8.4.1 Europe Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Digital Chronic Disease Management Market Size by Country (2021-2026)
- 8.4.3 Europe Digital Chronic Disease Management Market Size by Country (2027-2032)
- 8.4.4 Europe Digital Chronic Disease Management Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Digital Chronic Disease Management Market Size (2021-2032)
- 9.2 China Digital Chronic Disease Management Market Size by Type
- 9.2.1 China Digital Chronic Disease Management Market Size by Type (2021-2026)
- 9.2.2 China Digital Chronic Disease Management Market Size by Type (2027-2032)
- 9.2.3 China Digital Chronic Disease Management Market Share by Type (2021-2032)
- 9.3 China Digital Chronic Disease Management Market Size by Application
- 9.3.1 China Digital Chronic Disease Management Market Size by Application (2021-2026)
- 9.3.2 China Digital Chronic Disease Management Market Size by Application (2027-2032)
- 9.3.3 China Digital Chronic Disease Management Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Digital Chronic Disease Management Market Size (2021-2032)
- 10.2 Asia Digital Chronic Disease Management Market Size by Type
- 10.2.1 Asia Digital Chronic Disease Management Market Size by Type (2021-2026)
- 10.2.2 Asia Digital Chronic Disease Management Market Size by Type (2027-2032)
- 10.2.3 Asia Digital Chronic Disease Management Market Share by Type (2021-2032)
- 10.3 Asia Digital Chronic Disease Management Market Size by Application
- 10.3.1 Asia Digital Chronic Disease Management Market Size by Application (2021-2026)
- 10.3.2 Asia Digital Chronic Disease Management Market Size by Application (2027-2032)
- 10.3.3 Asia Digital Chronic Disease Management Market Share by Application (2021-2032)
- 10.4 Asia Digital Chronic Disease Management Market Size by Country
- 10.4.1 Asia Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Digital Chronic Disease Management Market Size by Country (2021-2026)
- 10.4.3 Asia Digital Chronic Disease Management Market Size by Country (2027-2032)
- 10.4.4 Asia Digital Chronic Disease Management Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Digital Chronic Disease Management Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Type
- 11.2.1 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Digital Chronic Disease Management Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Application
- 11.3.1 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Digital Chronic Disease Management Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Country
- 11.4.1 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Digital Chronic Disease Management Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Digital Chronic Disease Management Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst